Transfer pricing requires evidence for AMP transactions, functionally reliable comparables, and appropriate aggregation or Berry Ratio benchmarking me...
Revisionary jurisdiction cannot reopen share capital assessments where adequate inquiry supports a permissible view and no independent error is establ...
Reassessment jurisdiction fails where unverified portal information is aggregated without examining the taxpayer's explanation or relevance of entries...
Statutory sanction for delayed reassessment requires approval from the prescribed authority; approval by an inferior authority invalidates jurisdictio...
Transfer pricing margin adjustments require matching treatment of non-operating income and related costs, with comparability issues reconsidered on ev...
Preliminary-expense amortisation and MAT exempt-income adjustments prevailed, while trademark costs and managerial remuneration require fresh verifica...
Export valuation requires contemporaneous evidence; unrelated invoices cannot prove overvaluation, and dual penalties on firm and partner are impermis...
Six new Standard Input Output Norms have been fixed for Chemical and Allied Product Group A, covering Artemether PH.I/USP, Artesunate PH.I, Dihydro Artemisinin and three Doxycycline Hyclate DR tablet variants. The notified norms specify the corresponding import inputs and permitted quantities for each export product. The operative effect is to enable Regional Authorities to issue Advance Authorisations directly on the basis of these SIONs, avoiding case-by-case referral to the Norms Committee and promoting faster, more uniform approvals under the Foreign Trade Policy 2023.
Six new Standard Input Output Norms have been fixed for Chemical and Allied Product Group A, covering Artemether PH.I/USP, Artesunate PH.I, Dihydro Artemisinin and three Doxycycline Hyclate DR tablet variants. The notified norms specify the corresponding import inputs and permitted quantities for each export product. The operative effect is to enable Regional Authorities to issue Advance Authorisations directly on the basis of these SIONs, avoiding case-by-case referral to the Norms Committee and promoting faster, more uniform approvals under the Foreign Trade Policy 2023.
Note: It is a system-generated summary and is for quick reference only.